TY - JOUR
T1 - ASO Author Reflections
T2 - Improved Survival for Stage IV Breast Cancer: Considerations for Surgery in the Era of HER2-Targeted Therapy
AU - Mudgway, Ross
AU - Lum, Sharon S.
PY - 2020/8/1
Y1 - 2020/8/1
KW - Humans
KW - Female
KW - Molecular Targeted Therapy
KW - Neoplasm Staging
KW - Breast Neoplasms/drug therapy
KW - Randomized Controlled Trials as Topic
KW - Receptor, ErbB-2/metabolism
UR - https://www.scopus.com/pages/publications/85082017728
UR - https://www.scopus.com/pages/publications/85082017728#tab=citedBy
UR - https://www.mendeley.com/catalogue/02a9f2ea-72a5-376b-baf3-9af4e4e2f4eb/
U2 - 10.1245/s10434-020-08347-3
DO - 10.1245/s10434-020-08347-3
M3 - Comment/debate
C2 - 32170478
SN - 1068-9265
VL - 27
SP - 2721
EP - 2722
JO - Annals of surgical oncology
JF - Annals of surgical oncology
IS - 8
ER -